Ignite Creation Date:
2024-05-06 @ 9:25 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02973646
Status:
UNKNOWN
Last Update Posted:
2016-11-25
First Post:
2016-11-13
Brief Title:
Peginterferon Alfa-2b Treatment in HBeAg Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection
Sponsor:
Third Affiliated Hospital Sun Yat-Sen University
Organization:
Third Affiliated Hospital Sun Yat-Sen University
Study Overview
Official Title:
Investigation on Antiviral Therapy of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B Patients Based on Detection of Interferon Gene Mutation and Interferon Receptor
Status:
UNKNOWN
Status Verified Date:
2016-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is to observe the anti-HBV therapeutic effects of peginterferon alfa-2b in chronic hepatitis b patients with e antigen positive based on the detection of interferon gene mutation IFNA2 pAla120Thr and interferon receptor IFNAR2 detection
Detailed Description:
Patients with e antigen positive chronic hepatitis b were enrolled in the study Age sex symptoms eg fever fatigue poor appetite jaundice were recorded in the study We also observed the laboratory test results including the levels of white blood cells WBC red blood cells RBC hemoglobin HGB platelet PLT alanine transaminase ALT aspartate transaminase AST hepatitis B surface antigen HBsAg hepatitis B e antigen HBeAg hepatitis B e antibody HBeAb and hepatitis B virus HBV DNA detection of gene mutation IFNA2 pAla120Thr levels of interferon receptor IFNAR2
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None